These results, along with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two support the strategy of focusing on ACKR3 as a novel way to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders. A study research printed in https://bobh035hdx2.wikilentillas.com/user